The UC San Francisco Memory and Aging Center (MAC) has developed a new type of clinical trial for dementia aiming to accelerate treatments for neurodegenerative disease. By adapting one of the precision medicine approaches that have defined 21st century cancer...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
